Mikkel Højlund

Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis

Marco Solmi, Francesco Monaco, Mikkel Højlund et al. · World Psychiatry · 2024 · 233 citations · Full text

Medicine, Psychiatry, Behavioral Health +16

The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents

Christoph U. Correll, Marco Solmi, Samuele Cortese et al. · World Psychiatry · 2023 · 107 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016

Mikkel Højlund, Anton Pottegård, Erik Johnsen et al. · British Journal of Clinical Pharmacology · 2019 · 65 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +10

Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study

Mikkel Højlund, Kjeld Andersen, Martin Ernst et al. · World Psychiatry · 2022 · 54 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study

Helene Kildegaard, Lars Christian Lund, Mikkel Højlund et al. · BMJ · 2022 · 53 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17